Singapore: Japan-based Astellas Pharma and US-headquartered Ambit Biosciences are ending their collaboration for joint d...
Singapore: Roche has launched FLOW system, a user defined system for workflow chain from primary sample handling to qPCR...
Singapore: WHO and Global Fund to Fight AIDS, TB and Malaria have stressed on strains of tuberculosis with resistance to...
Singapore: US-based Edison Pharmaceuticals has entered into a strategic alliance valued up to $4.295 billion with Japan'...
Singapore: US-based Gilead Sciences has submitted a New Drug Application (NDA) to Japan's Pharmaceutical and Medical Dev...
Singapore: GlaxoSmithKline has recieved European Commission (EC) marketing authorisation for Mekinist (trametinib) as a ...
Singapore: Brisbane drug discovery and development company Alchemia announces that Mr Charles Walker has been appointed...
Singapore: Merck Millipore is boosting its portfolio for drug bioavailability, including products for all types of dosag...
Singapore: Singapore has announced 8 biomedical sciences research programmes to advance understanding and treatment of d...
Singapore: Boehringer Ingelheim, one of the world's leading pharmaceutical companies, will acquire the global rights of ...
Singapore: China's biomedical sector is rapidly transforming itself from a manufacturing base to an innovation hub, inve...
Singapore: Japan-based Astellas Pharma has received US FDA approval for Astagraf XL (tacrolimus extended-release capsule...
Over the last few decades India has reiterated its capabilities in providing dependable and cost effective chemistry ser...
Singapore: National Institutes of Health's (NIH) National Institute of Allergy and Infectious Diseases (NIAID) has provi...
Singapore: Janssen Biotech has entered into a license agreement with Astellas Pharma for the worldwide development and c...
Singapore: European Commission has approved Exjade (deferasirox) for the treatment of chronic iron overload requiring ch...
Singapore: CSL Behring's novel recombinant fusion protein linking coagulation factor IX with recombinant albumin (rIX-FP...
Singapore: Arthritis Foundation appointed Dr John Vernachio as vice president of research, effective April 15. In his ne...
